open access

Ahead of print
Research letter
Published online: 2020-09-04
Get Citation

Usability testing and satisfaction of “The Patient Access”: A mobile health application for patients with venous thromboembolic disease. A pilot study

Piotr Merks, Urszula Religioni, Karolina Arciszewska, Walentyn Pankiewicz, Miłosz Jaguszewski, Regis Vaillancourt
DOI: 10.5603/CJ.a2020.0107
·
Pubmed: 32914861

open access

Ahead of print
Research letter
Published online: 2020-09-04

Abstract

Background: Mobile phone applications are becoming more and more important in healthcare provision and can be an effective and accessible means of improving the safety and quality of healthcare. Mobile applications can particularly support patients with chronic diseases, including cardiological diseases. One of the major problems of medicine and public health is a venous thromboembolic disease (VTE). VTE patients often suffer from co-morbidities and take a large number of drugs. Therefore, constant monitoring of the therapy, including warnings about possible side effects or drug interactions, is essential among VTE patients. This study aims to assess the usefulness and satisfaction of “The Patient Access” mobile application targeted at patients with thrombotic disease.

Methods: The study included 16 people from VTE — potential users of the application. Patients were recruited in a community pharmacy in Bialystok, Poland. The study consists of quantitative and qualitative methods. The System Usability Scale questionnaire was used to measure usability.

Results: The results indicate that the application may be useful for patients with VTE. Overall utility on the System Usability Scale was estimated at 73.59 points. Patients indicated that the application’s advantages included information about the disease, drug reminders, or drug warnings. At the same time, the study showed that some of the functions should be developed.

Conclusions: The obtained results provided useful information that is necessary for the further development of the application for people with VTE disease.

Abstract

Background: Mobile phone applications are becoming more and more important in healthcare provision and can be an effective and accessible means of improving the safety and quality of healthcare. Mobile applications can particularly support patients with chronic diseases, including cardiological diseases. One of the major problems of medicine and public health is a venous thromboembolic disease (VTE). VTE patients often suffer from co-morbidities and take a large number of drugs. Therefore, constant monitoring of the therapy, including warnings about possible side effects or drug interactions, is essential among VTE patients. This study aims to assess the usefulness and satisfaction of “The Patient Access” mobile application targeted at patients with thrombotic disease.

Methods: The study included 16 people from VTE — potential users of the application. Patients were recruited in a community pharmacy in Bialystok, Poland. The study consists of quantitative and qualitative methods. The System Usability Scale questionnaire was used to measure usability.

Results: The results indicate that the application may be useful for patients with VTE. Overall utility on the System Usability Scale was estimated at 73.59 points. Patients indicated that the application’s advantages included information about the disease, drug reminders, or drug warnings. At the same time, the study showed that some of the functions should be developed.

Conclusions: The obtained results provided useful information that is necessary for the further development of the application for people with VTE disease.

Get Citation

Keywords

mHealth, mobile application, medicine, venous thromboembolic disease, System Usability Scale, testing

About this article
Title

Usability testing and satisfaction of “The Patient Access”: A mobile health application for patients with venous thromboembolic disease. A pilot study

Journal

Cardiology Journal

Issue

Ahead of print

Published online

2020-09-04

DOI

10.5603/CJ.a2020.0107

Pubmed

32914861

Keywords

mHealth
mobile application
medicine
venous thromboembolic disease
System Usability Scale
testing

Authors

Piotr Merks
Urszula Religioni
Karolina Arciszewska
Walentyn Pankiewicz
Miłosz Jaguszewski
Regis Vaillancourt

References (10)
  1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014; 12(10): 1580–1590.
  2. Kapitan-Malinowska B, Bogołowska-Stieblich A. Żylna choroba zakrzepowo-zatorowa. Post Nauk Med. 2009; 5: 345–354.
  3. Mangin D, Bahat G, Golomb BA, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action. Drugs Aging. 2018; 35(7): 575–587.
  4. Petrovic M, Somers A, Marien S, Spinewine A. Optimization of drug use in older people: a key factor for a successful ageing. In: The Cambridge Handbook of Successful Aging. Cambridge University Press, Cambridge 2019: 237–262.
  5. Burke LE, Ma J, Azar KMJ, et al. Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2015; 132(12): 1157–1213.
  6. Stinson JN, Jibb LA, Nguyen C, et al. Development and testing of a multidimensional iPhone pain assessment application for adolescents with cancer. J Med Internet Res. 2013; 15(3): e51.
  7. Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J Usability Studies. 2009; 4(3): 114–123.
  8. Brooke J. SUS – A quick and dirty usability scale [online]. Usability Evaluation in Industry. http://hell.meiert.org/core/pdf/sus.pdf (Accessed May 2, 2020).
  9. Lewis JR. Sample sizes for usability studies: additional considerations. Hum Factors J Hum Factors Ergon Soc. 1994; 36(2): 368–378.
  10. Sauro J. 10 Things To Know About The System Usability Scale (SUS) [online]. http://www.measuringusability.com/blog/10-things-SUS.php (May 2, 2020).

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl